The original brand name of oxandrolone was Anavar, which was marketed in the United States and the Netherlands .   This product was eventually discontinued and replaced in the United States with a new product named Oxandrin, which is the sole remaining brand name for oxandrolone in the United States.   Oxandrolone has also been sold under the brand names Antitriol ( Spain ), Anatrophill ( France ), Lipidex ( Brazil ), Lonavar ( Argentina , Australia , Italy ), Protivar, and Vasorome ( Japan ) among others.     Additional brand names exist for products that are manufactured for the steroid black market. 
Testoxyl Cypionate by Kalpa Pharmaceuticals offers bodybuilders large amounts of muscles and increases considerably the overall strength. It aromatizes easily and provides water retention. To avoid the negative effects of these processes is often stacked with other compounds. To achieve quality mass gain bodybuilders stack Testoxyl Cypionate 250 with drugs like Dianabol , Deca , Anadrol , or Equipoise . To avoid water retention or other negative side effects the drug should be stacked with Nolvadex or Proviron . Average Dosage: men 250-1000 mg per week, women – 50-100 mg. The usual cycle lasts from 8 to 20 weeks, or 10 weeks in some cases, depending on the goal of the user. Side effects: oily skin, gynocomastia, water retention, fat gain, loss of sex drive, acne, body and facial hair growth as well as common masculizing effects among women athletes.
Given YK11’s ability to significantly increase Follistatin production, along with its relatively weak activity at the androgen receptor, it’s likely that its myotrophic effects are mediated primarily through myostatin inhibition. If so, this would make YK11 a solid addition to just about any PED program, aside from those which already incorporate myostatin inhibitors. In my opinion, YK11 is one of the most interesting compounds to hit the market in recent years, but at this point most bodybuilders appear to be unaware, or at least unconcerned with its existence. I expect that to change in the days ahead, as we continue to learn more about it.